Follow
Spencer Jones
Spencer Jones
Research Scientist, Eli Lilly and Company
Verified email at lilly.com
Title
Cited by
Cited by
Year
Collective synthesis of natural products by means of organocascade catalysis
SB Jones, B Simmons, A Mastracchio, DWC MacMillan
Nature 475 (7355), 183-188, 2011
7132011
Nine-step enantioselective total synthesis of (+)-minfiensine
SB Jones, B Simmons, DWC MacMillan
Journal of the American Chemical Society 131 (38), 13606-13607, 2009
3692009
Total synthesis of (±)-hasubanonine
SB Jones, L He, SL Castle
Organic Letters 8 (17), 3757-3760, 2006
812006
Synthesis of isohasubanan alkaloids via enantioselective ketone allylation and discovery of an unexpected rearrangement
DK Nielsen, LL Nielsen, SB Jones, L Toll, MC Asplund, SL Castle
The Journal of Organic Chemistry 74 (3), 1187-1199, 2009
552009
Novel autotaxin inhibitors for the treatment of osteoarthritis pain: Lead optimization via structure-based drug design
SB Jones, LA Pfeifer, TJ Bleisch, TJ Beauchamp, JD Durbin, ...
ACS Medicinal Chemistry Letters 7 (9), 857-861, 2016
452016
A binding site on IL-17A for inhibitory macrocycles revealed by hydrogen/deuterium exchange mass spectrometry
A Espada, H Broughton, S Jones, MJ Chalmers, JA Dodge
Journal of medicinal chemistry 59 (5), 2255-2260, 2016
322016
Synthesis of the core structure of acutumine
MD Reeder, GSC Srikanth, SB Jones, SL Castle
Organic Letters 7 (6), 1089-1092, 2005
302005
Pharmacological characterization of a potent inhibitor of autotaxin in animal models of inflammatory bowel disease and multiple sclerosis
K Thirunavukkarasu, B Tan, CA Swearingen, G Rocha, HH Bui, ...
Journal of Pharmacology and Experimental Therapeutics 359 (1), 207-214, 2016
252016
Utilization of peptide phage display to investigate hotspots on IL-17A and what it means for drug discovery
JP Ting, F Tung, S Antonysamy, S Wasserman, SB Jones, FF Zhang, ...
PLoS One 13 (1), e0190850, 2018
232018
Identification and pharmacological characterization of a novel inhibitor of autotaxin in rodent models of joint pain
K Thirunavukkarasu, CA Swearingen, JL Oskins, C Lin, HH Bui, SB Jones, ...
Osteoarthritis and Cartilage 25 (6), 935-942, 2017
172017
Bicyclic pyrimidine compounds
TJ Beauchamp, Y Dao, SB Jones, BH Norman, LA Pfeifer
US Patent 8,969,555, 2015
162015
Imidazo pyridine compounds
SB Jones, BH Norman, LA Pfeifer
US Patent 9,394,317, 2016
62016
Formal γ-C(sp3)–H Activation of Ketones via Microwave-Promoted and Iminyl-Radical-Mediated 1,5-Hydrogen Atom Transfer
J Singh, SA Jones, TJ Nelson, JA Botello, SL Castle
The Journal of Organic Chemistry 88 (14), 10287-10297, 2023
22023
Pyrido-or pyrrolo-fused pyrimidine derivatives as autotaxin inhibitors for treating pain
TJ Beauchamp, Y Dao, SB JONES, BH Norman, LA Pfeifer
12014
Safety, Tolerability, and Pharmacokinetics of an Oral Small Molecule Inhibitor of IL‐17A (LY3509754): A Phase I Randomized Placebo‐Controlled Study
A Datta‐Mannan, A Regev, DE Coutant, AJ Dropsey, J Foster, S Jones, ...
Clinical Pharmacology & Therapeutics, 2024
2024
Not Logged In Login
JJ Topczewski, MR Porter
Synlett 29 (12), 1537-1542, 2018
2018
Derivados de pirimidina pirido-o pirrolo-fusionados como inhibidores de autotaxina para el tratamiento del dolor
TJ Beauchamp, Y Dao, SB Jones, BH Norman, LA Pfeifer
2017
Pyrido-or pyrrolo-fused pyrimidine derivatives as autotaxin inhibitors for treating pain
TJ Beauchamp, Y Dao, SB Jones, BH Norman, LA Pfeifer
2017
Hydrogen/deuterium exchange mass spectrometry in the drug discovery scene: Application to protein-protein interactions
A Espada, H Broughton, J Dodge, S Jones, S Afshar, M Grogan, ...
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 251, 2016
2016
Identification of novel autotaxin inhibitors: Lead optimization through structure based drug design
S Jones, L Pfeifer, B Norman, N Hughes, T Bleisch, T Beauchamp, C Rito, ...
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 250, 2015
2015
The system can't perform the operation now. Try again later.
Articles 1–20